Celgene Employee Reviews about "big pharma"

Updated May 20, 2020

To filter reviews, or .

Found 16 of over 566 reviews

4.1
77%
Recommend to a Friend
64%
Approve of CEO
Celgene Chairman and CEO Mark J. Alles
Mark J. Alles
153 Ratings
Pros
  • "Great pay, stock options, bonus(in 41 reviews)

  • "Great company, lots of opportunities to learn and grow(in 32 reviews)

  • Cons
  • "hard to achieve work life balance(in 31 reviews)

  • "Slowly Turning into big pharma; very little internal advancement; not much room for growth; Very tight timelines(in 16 reviews)

  • More Pros and Cons
    Pros & Cons are excerpts from user reviews. They are not authored by Glassdoor.

    Reviews about "big pharma"

    Return to all Reviews
    1. 4.0
      Former Employee

      Great Place To Work

      May 20, 2020 - Market Access in Brazil, IN
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Collaborative environment, dynamic culture, innovative

      Cons

      The company was acquired by a big pharma.

      Be the first to find this review helpful
    2. 5.0
      Current Employee, more than 3 years

      Was a very special place to work

      Dec 9, 2019 - Manager in Summit, NJ
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Celgene was a truly amazing place to work. The best place I have worked in my career. Very fast paced and demanding, but if you work hard and are smart you can flourish. Being part of a talented project team bringing treatment for unmet medical needs to market has meant a lot to me

      Cons

      It’s already apparent that the big-pharma culture at BMS is not aligned with the agile biotech culture that defined Celgene. It’s turning out to be the case that the same job one person has at Celgene is managed by 5 or more people at BMS. This means a lot of talent will be mapped into positions that minimize their potential. There is a lack of confidence that BMS will value the talent and expertise Celgene employees bring to the table. The majority of the late stage pipeline BMS now owns is thanks to the hard work and dedication of Celgene’s workforce, but BMS is already pushing to fit everything into their model which is alarming. I loved being part of Celgene and am deeply saddened what made it special will likely go away.

      Continue reading
      4 people found this review helpful
    3. 3.0
      Former Contractor, more than 1 year

      A very mixed bag

      Aug 15, 2018 - Consultant in Boudry
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Some lovely, well-meaning people even though the sector is of questionable merit

      Cons

      Too many misleading job titles and conflicting responsibilities. Parochial attitudes across affiliates. This is Big Pharma.

      Continue reading
      Be the first to find this review helpful
    4. 3.0
      Current Employee, more than 8 years

      Getting more like a big pharma rather than biotech in recent 2 yrs

      Dec 7, 2017 - Scientist in Summit, NJ
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Stock option. RSU. 401(K) match is similar to any other pharma but in form of com stock. generous health care, prescription drug benefit.

      Cons

      Recent 2 years, the company was undergoing tremendous culture change. The management team should know it and prob heard old folks talking quite a bit. In one sentence, Celg is more like 2 big pharma at Kenilworth, NJ (both 10 yr ago and now) rather than a biotech at Summit, NJ 10 yr ago. Go figure out who they are!

      Continue reading
      1 person found this review helpful
    5. 3.0
      Current Employee, more than 5 years

      Scientist at Celgene

      Apr 7, 2017 - Anonymous Employee in Summit, NJ
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Good compensation package; Talented employees; Friendly environment

      Cons

      Slowly Turning into big pharma; very little internal advancement; not much room for growth; Very tight timelines

      2 people found this review helpful
    6. 3.0
      Current Employee, more than 5 years

      Director Commercial

      Feb 2, 2017 - Director in San Francisco, CA
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Smart colleagues, good compensation and patient centric company. Innovative medicines that are market leaders. Strong pipeline and business acquisitions. Expanding from a Hem/Onc business into inflammation and immunology.

      Cons

      Changes in Senior Leadership and current culture are bringing down this once amazing company. Becoming more like Big Pharma than biotech.

      Continue reading
      1 person found this review helpful
    7. 4.0
      Current Employee

      Good company, in danger of developing a "big pharma" attitude

      Sep 24, 2016 -  
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Good work environment with passionate people dedicated to the patient.

      Cons

      Moving towards becoming big pharma, a few bad egg managers creating internal politics and toxic environment

      Continue reading
      4 people found this review helpful
    8. 4.0
      Former Employee

      great company and mission, high burnout

      Sep 6, 2016 -  
      Recommend
      CEO Approval
      Business Outlook

      Pros

      smart people great equity higher purpose company is financially sound and well-respected

      Cons

      high degree of burnout in certain departments internal politics becoming big pharma disparate treatment of different groups (eg, some have summer hours, some do not)

      Continue reading
      2 people found this review helpful
    9. 4.0
      Current Employee

      Excellent company to work for!

      Apr 18, 2016 -  
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Culture, stock option compensation, benefits,

      Cons

      Culture is changing from small biotech to big pharma slowly but surely.

      Continue reading
      1 person found this review helpful
    10. 3.0
      Current Employee

      Great company but too political

      Mar 28, 2016 - Product Manager in Summit, NJ
      Recommend
      CEO Approval
      Business Outlook

      Pros

      Compensation, culture, smart people, growing organization/energy, multiple products. Restricted stock units! Overall, good culture, energy, and work environment. Lean organization so opportunity to take on more work and learn faster

      Cons

      Slowly becoming big pharma/hierarchical. Career progression can be hit or miss depending on political standing within organization. Depends on how much superiors with political capital 'advocate' for you. Some deserving people are passed over for promotions because of favoritism and inconsistency across the organization.

      Continue reading
      7 people found this review helpful
    Viewing 1 - 10 of 16 Reviews

    Popular Careers with Celgene Job Seekers

    JobsSalariesInterviews

    Work at Celgene? Share Your Experiences

    Celgene logo
    or